Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
Email Facebook Twitter Google+ LinkedIn Comments

MIP Technologies AB

Feb 2009
MIP Technologies AB of Lund, Sweden, has entered into a collaboration with sanofi-aventis of Paris to develop molecularly imprinted polymers that will be used to analyze pharmacologically active peptides from plasma samples. The French company will have exclusive rights to use the polymer for analyzing proprietary peptides, while the Swedish company will retain the rights for its use in other applications.

BiophotonicsMIP Technologies ABmolecularly imprinted polymersNews & Features

Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA,

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.